Congenital Disorders of Glycosylation

Gene: ALG2

Green List (high evidence)

ALG2 (ALG2, alpha-1,3/1,6-mannosyltransferase)
EnsemblGeneIds (GRCh38): ENSG00000119523
EnsemblGeneIds (GRCh37): ENSG00000119523
OMIM: 607905, Gene2Phenotype
ALG2 is in 10 panels

2 reviews

Chirag Patel (Genetic Health Queensland)

Green List (high evidence)

ClinGen: 'STRONG' for ALG2-congenital disorder of glycosylation

Patients have a range of range of symptoms, such as developmental delay, seizures, poor vision, coagulopathy, and delayed myelinization. Patients may also present with congenital myasthenic syndromes (CMS) which characterized by fatigable muscle weakness.
Created: 2 Oct 2025, 12:27 p.m. | Last Modified: 2 Oct 2025, 12:27 p.m.
Panel Version: 1.73

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Congenital disorder of glycosylation, type Ii, MIM# 607906

Publications

Ain Roesley (Victorian Clinical Genetics Services)

Red List (low evidence)

PMID: 12684507
- 1x patient with multisystemic disorder with mental retardation, seizures, coloboma of the iris, hypomyelination, hepatomegaly, and coagulation abnormalities. Fibroblasts showed severely reduced enzymatic activity.

PMID: 23404334
- 2x families with Congenital myasthenic syndrome. Authors claimed the standard transferrin glycoform analysis did not show any abnormalities suggesting only modest impairment of N-linked glycosylation. However data was not shown.

PMID: 24461433
- 3 affecteds in 1 consanguineous family. 1 has normal transferrin results and 2x mildly elevated
Created: 15 Jul 2020, 12:19 p.m. | Last Modified: 15 Jul 2020, 12:19 p.m.
Panel Version: 0.57

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Congenital disorder of glycosylation, type Ii (MIM# 607906)

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
Phenotypes
  • Congenital disorder of glycosylation, type Ii (MIM# 607906)
OMIM
607905
Clinvar variants
Variants in ALG2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

2 Oct 2025, Gel status: 3

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: alg2 has been classified as Green List (High Evidence).

15 Jul 2020, Gel status: 1

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: alg2 has been classified as Red List (Low Evidence).

15 Jul 2020, Gel status: 1

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: ALG2 were changed from to Congenital disorder of glycosylation, type Ii (MIM# 607906)

15 Jul 2020, Gel status: 1

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: ALG2 were set to

15 Jul 2020, Gel status: 1

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: ALG2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

15 Jul 2020, Gel status: 1

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: alg2 has been classified as Red List (Low Evidence).

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: ALG2 was added gene: ALG2 was added to Congenital Disorders of Glycosylation_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: ALG2 was set to Unknown